<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Sanofi SA (ADR) - Google Finance</title>
<description>News for Sanofi SA (ADR) - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:SNY&amp;amp;client=news-rss&amp;amp;ei=SnzBUZjyAcWg0AHUfw</link>
<image>
<title>News for Sanofi SA (ADR) - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:SNY&amp;amp;client=news-rss&amp;amp;ei=SnzBUZjyAcWg0AHUfw</link>
</image>
<item>
<title>This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)</title>
<link>http://www.insidermonkey.com/blog/this-metric-says-you-are-smart-to-buy-sanofi-sa-adr-sny-149140/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/this-metric-says-you-are-smart-to-buy-sanofi-sa-adr-sny-149140/</guid>
<pubDate>Fri, 24 May 2013 13:49:25 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/this-metric-says-you-are-smart-to-buy-sanofi-sa-adr-sny-149140/&quot; style=&quot;font-size:1.2em&quot;&gt;This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;To most investors, hedge funds are seen as slow, outdated financial vehicles of the past. While there are more than 8000 funds in operation at the moment, we look at the leaders of this group, around 450 funds.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Why The Pfizer Inc. (PFE)-Teva Pharmaceutical Industries Ltd (ADR) (TEVA ...</title>
<link>http://www.insidermonkey.com/blog/why-the-pfizer-inc-pfe-teva-pharmaceutical-industries-ltd-adr-teva-settlement-affects-the-whole-industy-170214/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/why-the-pfizer-inc-pfe-teva-pharmaceutical-industries-ltd-adr-teva-settlement-affects-the-whole-industy-170214/</guid>
<pubDate>Thu, 13 Jun 2013 18:44:31 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/why-the-pfizer-inc-pfe-teva-pharmaceutical-industries-ltd-adr-teva-settlement-affects-the-whole-industy-170214/&quot; style=&quot;font-size:1.2em&quot;&gt;Why The Pfizer Inc. (PFE)-Teva Pharmaceutical Industries Ltd (ADR) (TEVA ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;In 2006, Apotex made an at-risk launch of its generic version of Plavix -- sold by Sanofi SA (ADR) (NYSE:SNY) and Bristol-Myers Squibb Co.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>5 Costliest Microbes in Financial History</title>
<link>http://www.fool.com/investing/general/2013/05/28/5-costliest-microbes-in-financial-history.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982076896491</guid>
<pubDate>Tue, 28 May 2013 22:35:22 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.com/investing/general/2013/05/28/5-costliest-microbes-in-financial-history.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;5 Costliest Microbes in Financial History&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 28, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;In 2009, biotechnology trailblazer Genzyme, now a part of Sanofi (NYSE: SNY ) , demonstrated the worst-case scenario facing investors of today&amp;#39;s biotechnology and industrial biotech companies: contamination.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Biotechs Lose Ground As Achillion Pharmaceuticals, Inc. (ACHN) Takes a Dive</title>
<link>http://www.insidermonkey.com/blog/biotechs-lose-ground-as-achillion-pharmaceuticals-inc-achn-takes-a-dive-171985/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/biotechs-lose-ground-as-achillion-pharmaceuticals-inc-achn-takes-a-dive-171985/</guid>
<pubDate>Mon, 17 Jun 2013 12:31:51 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/biotechs-lose-ground-as-achillion-pharmaceuticals-inc-achn-takes-a-dive-171985/&quot; style=&quot;font-size:1.2em&quot;&gt;Biotechs Lose Ground As Achillion Pharmaceuticals, Inc. (ACHN) Takes a Dive&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Like Biogen, however, Regeneron Pharmaceuticals Inc (NASDAQ:REGN)&amp;#39;s a company with a drug preparing for a strong future. The company&amp;#39;s asthma therapy dupilumab, made jointly with Big Pharma&amp;#39;s Sanofi SA (ADR) (NYSE:SNY), absolutely crushed a&amp;nbsp;...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Morning News: Apple, Google, McDonald&amp;#39;s, Berkshire, AstraZeneca, IHS</title>
<link>http://www.valuewalk.com/2013/06/morning-news-apple-google-mcdonalds-berkshire-astrazeneca-ihs/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.valuewalk.com/2013/06/morning-news-apple-google-mcdonalds-berkshire-astrazeneca-ihs/</guid>
<pubDate>Mon, 10 Jun 2013 13:20:48 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.valuewalk.com/2013/06/morning-news-apple-google-mcdonalds-berkshire-astrazeneca-ihs/&quot; style=&quot;font-size:1.2em&quot;&gt;Morning News: Apple, Google, McDonald&amp;#39;s, Berkshire, AstraZeneca, IHS&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;ValueWalk&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;French drug maker Sanofi SA (ADR) (NYSE:SNY) said its Sanofi Pasteur vaccines division has secured clearance from the U.S.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics ...</title>
<link>http://www.insidermonkey.com/blog/immunogen-inc-imgn-seattle-genetics-inc-sgen-celldex-therapeutics-inc-cldx-a-trio-of-cancer-immunotherapy-innovators-171333/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/immunogen-inc-imgn-seattle-genetics-inc-sgen-celldex-therapeutics-inc-cldx-a-trio-of-cancer-immunotherapy-innovators-171333/</guid>
<pubDate>Fri, 14 Jun 2013 19:13:45 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/immunogen-inc-imgn-seattle-genetics-inc-sgen-celldex-therapeutics-inc-cldx-a-trio-of-cancer-immunotherapy-innovators-171333/&quot; style=&quot;font-size:1.2em&quot;&gt;ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... Inc. (NASDAQ:IMGN) has partnerships with Roche, Bayer, Sanofi SA (ADR) (NYSE:SNY), Biotest, Amgen, Inc. (NASDAQ:AMGN), and most recently Novartis AG (ADR) (NYSE:NVS), each yielding milestone payments and royalties upon commercialization.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Sanofi SA (SNY): FDA Licenses New Four-Strain Influenza Vaccine</title>
<link>http://www.istockanalyst.com/finance/story/6455297/sanofi-sa-sny-fda-licenses-new-four-strain-influenza-vaccine</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778178672332</guid>
<pubDate>Mon, 10 Jun 2013 12:11:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.istockanalyst.com/finance/story/6455297/sanofi-sa-sny-fda-licenses-new-four-strain-influenza-vaccine&quot; style=&quot;font-size:1.2em&quot;&gt;Sanofi SA (SNY): FDA Licenses New Four-Strain Influenza Vaccine&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;iStockAnalyst (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(By Balachander) Sanofi SA (NYSE: SNY) said the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for licensure of its four-strain influenza vaccine, Fluzone Quadrivalent vaccine, for broad age ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Regeneron Pharmaceuticals Inc. (REGN), GlaxoSmithKline plc (GSK): The First ...</title>
<link>http://www.insidermonkey.com/blog/regeneron-pharmaceuticals-inc-regn-glaxosmithkline-plc-gsk-the-first-real-cure-in-the-25-billion-asthma-market-168338/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778180332425</guid>
<pubDate>Wed, 12 Jun 2013 15:52:07 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/regeneron-pharmaceuticals-inc-regn-glaxosmithkline-plc-gsk-the-first-real-cure-in-the-25-billion-asthma-market-168338/&quot; style=&quot;font-size:1.2em&quot;&gt;Regeneron Pharmaceuticals Inc. (REGN), GlaxoSmithKline plc (GSK): The First ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 12, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) are developing dupilumab to cure moderate to severe allergic asthma.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Hedge Funds Are Dumping Merck &amp;amp; Co., Inc. (MRK)</title>
<link>http://www.insidermonkey.com/blog/hedge-funds-are-dumping-merck-co-inc-mrk-148842/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982070801449</guid>
<pubDate>Thu, 23 May 2013 19:13:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/hedge-funds-are-dumping-merck-co-inc-mrk-148842/&quot; style=&quot;font-size:1.2em&quot;&gt;Hedge Funds Are Dumping Merck &amp;amp; Co., Inc. (MRK)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;These stocks are Johnson &amp;amp; Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Novartis AG (ADR) (NYSE:NVS), GlaxoSmithKline plc (ADR) (NYSE:GSK), and Sanofi SA (ADR) (NYSE:SNY). This group of stocks are in the drug manufacturers - major industry and&amp;nbsp;...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer, Takeda To Get Total $2.15 Billion In Patent Settlement</title>
<link>http://www.4-traders.com/PFIZER-INC-4821/news/Pfizer-Takeda-To-Get-Total-$2-15-Billion-In-Patent-Settlement-17018456/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.4-traders.com/PFIZER-INC-4821/news/Pfizer-Takeda-To-Get-Total-$2-15-Billion-In-Patent-Settlement-17018456/</guid>
<pubDate>Wed, 12 Jun 2013 12:39:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/PFIZER-INC-4821/news/Pfizer-Takeda-To-Get-Total-$2-15-Billion-In-Patent-Settlement-17018456/&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer, Takeda To Get Total $2.15 Billion In Patent Settlement&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 12, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Teva Pharmaceutical Industries Ltd. (&amp;gt;&amp;gt; Teva Pharmaceutical Industries Ltd (ADR)) will pay $1.6 billion and Sun Pharmaceutical Industries Ltd.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
